1. Home
  2. Africa
  • News

MSF pressures Abbott on key ARV

US drug giant Abbott Laboratories was on Thursday accused of withholding new heat-resistant tablet versions of its anti-AIDS drug Kaletra in developing countries.

International medical NGO, Medecins San Frontieres (MSF), said current refrigerated liquid versions of the drug being used in resource-limited settings, was creating treatments hurdles.

MSF president Rowan Gillies said in a statement: "... where refrigerators are a luxury, [Kaletra] is urgently needed by patients switching to second-line AIDS treatment. How can Abbott continue to drag its feet in filing for registration in most African countries?"

Kaletra is a key second-line treatment that is used after HIV-positive people naturally develop resistance to first-line combinations.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join